Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
ORIC stock price ended at $5.14 on Monday, after rising8.67%
The Oric Pharmaceuticals Inc stock price increased by 8.67% on the last trading day (19 May 2025), rising from 4.8 to 5.14. Throughout the last trading session, the stock experienced a fluctuation of 11.37% , ranging from a day low of $4.66 to a day high of 5.19. The price has declined in 7 of the last 10 days, resulting in a total change of -9.82% during this period. On the last day, trading volume increase by 140.76K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 771.39K shares were traded, amounting to approximately 3.81M.
ORIC Technical Signals
ORIC(Oric Pharmaceuticals Inc Corp) has 3 buy signals and 3 sell signals now. The current trend is uptrend starting from 2025-05-07. The total price change during this trend is +0.64%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of ORIC over the last 5 trading days is 2.39M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
ORIC Moving Average Analysis
Oric Pharmaceuticals Inc's overall moving average trend leans more bearish as of Tuesday, May 20, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $5.95608, and $6.4565. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.336919999999999, and $3.836499999999999. A break-down below any of these levels will issue sell signals.
ORIC Short Selling Analysis
The short sale ratio of Oric Pharmaceuticals Inc(ORIC) as of 12 May 2025 is 16.52%, dropping from last trading day. With decreasing price from 5.08 to 5.41. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
3
Buy
3
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
18.72
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-124.862
Bullish
Williams %R (14 days)
WILLR_14 < -80
-84.783
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.0568
Bearish
Momentum (10 days)
MOM_10 < 0
-0.94
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.218
Bearish
ORIC Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Oric Pharmaceuticals Inc(ORIC), our algorithm predicts ORIC's 1-month price at $5.71, with an 12.34%upwardshift. Using a similarity score up to 92.99%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of Sunday, May 11, 2025 , forecasts a 12.34% change over the next month, based on its high correlation with IRON.O stock patterns. The similarity between their price movements over the analyzed periods is 92.99%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ORIC
No Data
IRON
Up: 12.34%Similarity: 92.99%
Name
Similarity
Up/Down
IRON.O
92.99%
+12.34%
WVE.O
92.21%
-1.90%
FRO.N
90.53%
-12.71%
ORIC Seasonality Analysis
Based on ORIC's historical stock price data across all years, the probability of a positive return in May is40.00%, suggesting it maynotbe an ideal month to invest in ORIC. In contrast,Novemberoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).
Performance Seasonality
The chart shows Oric Pharmaceuticals Inc. (ORIC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Oric Pharmaceuticals Inc (ORIC.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Oric Pharmaceuticals Inc (ORIC.O) stock in a year?
The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).
How has Oric Pharmaceuticals Inc. (ORIC)'s stock price performed over the past three years?
ORIC's stock price rose by 53.59% in 2023,decreased by -11.71% in 2024, and went down by 37.77% in 2025.
Is ORIC a buy based on overall technical signals summary?
ORIC has 3 buy signals and 3 sell signals now. Overall the technical rating for ORIC is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ORIC.
What is the trend of Oric Pharmaceuticals Inc (ORIC)'s moving average?
Oric Pharmaceuticals Inc's overall moving average trend leans more bearish as of May 20 2025, with 3 negative signals and 1 positive signal.
What is price prediction for ORIC stock next month?
The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of May 11 2025, forecasts a 12.34% change over the next month, based on its high correlation with IRON stock patterns. The similarity between their price movements over the analyzed periods is 92.99%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ORIC Stock?
### **Price Prediction for ORIC Stock in 2025**
ORIC Pharmaceuticals, Inc. (ORIC) is expected to trade between **$18 and $22** by the end of 2025.
The stock is currently undervalued, with positive trial data and analyst upgrades driving optimism.
The $21 price target from HC Wainwright supports this bullish outlook.
What is price prediction 2030 for ORIC Stock?
### **Price Prediction for ORIC Stock by 2030**
ORIC Pharmaceuticals (ORIC) is a clinical-stage oncology company focused on developing treatments for cancer. Based on current data and analysis, here is a concise price prediction for ORIC stock by 2030:
1. **Bullish Scenario**: ORIC stock could reach **$35-$45** by 2030 if its lead candidates, ORIC-944 and ORIC-114, achieve successful Phase 3 trial results and gain FDA approval, capturing significant market share in targeted cancer therapies.
2. **Base Scenario**: A more moderate price target of **$25-$35** is possible if the company demonstrates incremental progress in its pipeline, with one drug achieving commercial success and the other showing promise but requiring additional development.
3. **Bearish Scenario**: The stock could trade in the **$10-$20 range** if clinical trials face setbacks or competition intensifies in the oncology space.
**Key Drivers**:
- **Pipeline Success**: ORIC-944 and ORIC-114 are in critical stages of development, with Phase 3 trials expected to start in 2026.
- **Market Opportunity**: Targeted therapies in oncology are a high-growth market, and ORIC's focus on resistance mechanisms positions it well.
- **Financial Health**: The company has a cash runway into 2027, providing stability for development.